Home Use of Dual-light Photodynamic Therapy for Chronic Periodontitis

NCT ID: NCT05425784

Last Updated: 2025-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-19

Study Completion Date

2025-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This early-stage research is designed to determine the efficacy of the Lumoral method in chronic periodontitis patients. Improved supragingival plaque control can help to also sustain the subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Periodontitis is a chronic inflammatory disease leading to a progressive loss of the tooth-supporting apparatus. The disease is strongly associated with deranged biodiversity patterns in dental plaque.

The Lumoral is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial photodynamic therapy. The device is used by swishing a mouth rinse, which has a strong adherence to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple to use light applicator. The antibacterial efficacy far exceeds chlorhexidine, without side effects in a longterm use. Preliminary results have shown a promising anti-inflammatory response in addition to plaque reduction.

Ninety (90) stage I-III periodontitis patients are randomized to Lumoral treatment group or control group. Both groups shall receive mechanical plaque control by scaling and root planning (SRP) and standard oral hygiene instructions for electric toothbrush, interdental brush, and dental floss use. All the patients shall be assessed for the clinical periodontitis status. These assessment and analyses shall be performed at baseline, at 3 months and at 6 months after the treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontal Diseases Periodontitis Plaque, Dental Plaque Induced Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

90 participants are randomized into two arms: the Lumoral-treatment arm and Control arm.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators
The subjects will be randomized to the study group and the control group by using a sealed envelope system.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lumoral Treatment (Study group)

Subjects will receive detailed instructions for the use of Lumoral treatment -device and Lumorinse -tablets. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol five to seven (5-7) times a week. Regular use shall be defined as frequency of a minimum of twice a week.

Standard oral hygiene instructions will be provided verbally and in writing. In addition, an electric toothbrush will be provided to all subjects.

Group Type EXPERIMENTAL

Lumoral treatment

Intervention Type DEVICE

The investigational Lumoral treatment -device provides a constant and repeatable application which can be done at home and is easily available. All subjects in the study group will receive their own Lumoral treatment -device and Lumorinse-mouth rinse tablets for the complete duration of the study.

Standard oral hygiene self care

Intervention Type OTHER

Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self-care.

Standard of care (Control group)

Standard oral hygiene instructions will be provided verbally and in writing. In addition, an electric toothbrush will be provided to all subjects.

Group Type ACTIVE_COMPARATOR

Standard oral hygiene self care

Intervention Type OTHER

Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self-care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lumoral treatment

The investigational Lumoral treatment -device provides a constant and repeatable application which can be done at home and is easily available. All subjects in the study group will receive their own Lumoral treatment -device and Lumorinse-mouth rinse tablets for the complete duration of the study.

Intervention Type DEVICE

Standard oral hygiene self care

Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self-care.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lumorinse mouth rinse Electric toothbrush provided

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Periodontal disease stage I-III, according to criteria the American Academy of Periodontology (AAP) with at least 2 mm interdental CAL in the site of greatest loss.
* Age of 18- 85 years
* Presence of ≥20 teeth, including implants
* Agreement to participate in the study and to sign a written consent form
* Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol

Exclusion Criteria

* Presence of major physical limitation or restriction that prohibit the hygiene procedures used in the study protocol
* Removable major prosthesis or major orthodontic appliance
* Pregnancy or lactation
* Use of antibiotics within 2 weeks prior the study
* A need for immediate antimicrobial treatment for periodontitis
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Helsinki

OTHER

Sponsor Role collaborator

University of Oulu

OTHER

Sponsor Role collaborator

Koite Health Oy

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tommi Pätilä, Docent

Role: STUDY_DIRECTOR

Chief Medical Officer

Timo Sorsa, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Helsinki

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mehiläinen Länsi-Pohja Central Hospital

Kemi, Lapland, Finland

Site Status

Hammas Hohde Oy

Oulu, Oulun Lääni, Finland

Site Status

City of Rovaniemi Health Cervices, Oral Health

Rovaniemi, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Related Links

Access external resources that provide additional context or updates about the study.

https://link.springer.com/article/10.1007/s41547-019-00056-9

Alaijah, F., Morsi, A., Nasher, R. et al. Photobiomodulation therapy in the treatment of periodontal disease: a literature review.

https://pubmed.ncbi.nlm.nih.gov/31783161/

Joshi K, Baiju CS, Khashu H, Bansal S (2020) Clinical effectiveness of indocyanine green mediated antimicrobial photodynamic therapy as an adjunct to scaling root planing in treatment of chronic periodontitis- A randomized controlled clinical trial.

https://pubmed.ncbi.nlm.nih.gov/25261053/

Kassebaum NJ, Bernabé E, Dahiya M et al., (2014) Global burden of severe periodontitis in 1990- 2010: a systematic review and meta-regression.

https://pubmed.ncbi.nlm.nih.gov/28792274/

Kassebaum NJ, Smith AGC, Bernabé E, et al., (2017) Global, Regional and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990-2015: A Systematic Analysis for the Global Burden of Diseases, Injuries

https://pubmed.ncbi.nlm.nih.gov/25496279/

Lang NP, Suvan JE, Tonetti MS (2015) Risk factor assessment tools for the prevention of periodontitis progression a systematic review.

https://www.fda.gov/media/75892/download

Levine JI. Medications that increase photosensititivity. FDA document Dec 1990.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670400/

Loos BG \& Needleman I (2020) Endpoints of active periodontal therapy.

https://pubmed.ncbi.nlm.nih.gov/26921460/

Monzavi A, Chinipardaz Z, Mousavi M, et al., (2016) Antimicrobial photodynamic therapy using diode laser activated indocyanine green as an adjunct in the treatment of chronic periodontitis: A randomized clinical trial.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232775

Nikinmaa S, Alapulli H, Auvinen P, et al. (2020) Dual-light photodynamic therapy administered daily provides a sustained antibacterial effect on biofilm and prevents Streptococcus mutans adaptation.

https://pubmed.ncbi.nlm.nih.gov/28259623/

Pereira PAB, Aho VTE, Paulin L, et al., (2017) Oral and nasal microbiota in Parkinson's disease.

https://pubmed.ncbi.nlm.nih.gov/32383274/

Sanz M, Herrera D, Kebschull M, et al.; On behalf of the EFP Workshop Participants and Methodological Consultants. (2020) Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline.

https://doi.org/10.1016/j.pdpdt.2020.101971

Schär D, Ramseier CA, Eick S, et al., (2020) Transgingival photodynamic therapy (tg-aPDT) adjunctive to subgingival mechanical instrumentation in supportive periodontal therapy. A randomized controlled clinical study.

https://pubmed.ncbi.nlm.nih.gov/9332805/

Slade GD (1997) Derivation and validation of a short-form oral health impact profile

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LumoNorth2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of Laser Therapy for Periodontitis
NCT07013162 NOT_YET_RECRUITING NA